55.13
price down icon2.42%   -1.37
after-market Dopo l'orario di chiusura: 56.19 1.06 +1.92%
loading
Precedente Chiudi:
$56.50
Aprire:
$56.33
Volume 24 ore:
904.19K
Relative Volume:
1.08
Capitalizzazione di mercato:
$3.09B
Reddito:
$665.13M
Utile/perdita netta:
$64.50M
Rapporto P/E:
48.18
EPS:
1.1442
Flusso di cassa netto:
$185.87M
1 W Prestazione:
+4.35%
1M Prestazione:
+15.36%
6M Prestazione:
+69.74%
1 anno Prestazione:
+61.81%
Intervallo 1D:
Value
$54.21
$57.33
Intervallo di 1 settimana:
Value
$51.84
$57.65
Portata 52W:
Value
$29.16
$57.65

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
Nome
Supernus Pharmaceuticals Inc
Name
Telefono
301-838-2500
Name
Indirizzo
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
Dipendente
674
Name
Cinguettio
@Supernus_Pharma
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
SUPN's Discussions on Twitter

Confronta SUPN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
55.13 3.17B 665.13M 64.50M 185.87M 1.1442
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-09 Aggiornamento Piper Sandler Neutral → Overweight
2025-07-30 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2025-02-19 Downgrade Cantor Fitzgerald Overweight → Neutral
2025-01-06 Iniziato Cantor Fitzgerald Overweight
2024-09-11 Downgrade Piper Sandler Overweight → Neutral
2023-01-03 Ripresa Jefferies Buy
2021-12-01 Ripresa Jefferies Buy
2021-04-13 Aggiornamento Jefferies Hold → Buy
2020-06-16 Aggiornamento Piper Sandler Neutral → Overweight
2020-06-15 Ripresa Jefferies Hold
2019-11-08 Downgrade Berenberg Buy → Hold
2019-11-07 Downgrade Stifel Buy → Hold
2019-11-06 Downgrade Jefferies Buy → Hold
2018-11-12 Reiterato B. Riley FBR Buy
2018-01-18 Reiterato B. Riley FBR, Inc. Buy
2017-12-28 Reiterato B. Riley FBR, Inc. Buy
2017-12-04 Aggiornamento Janney Neutral → Buy
2017-11-08 Aggiornamento Stifel Hold → Buy
2017-10-19 Iniziato FBR & Co. Buy
2017-09-19 Downgrade Stifel Buy → Hold
2017-07-17 Downgrade Piper Jaffray Overweight → Neutral
2017-07-14 Iniziato Janney Neutral
2017-06-01 Aggiornamento Piper Jaffray Neutral → Overweight
2016-07-18 Downgrade Northland Capital Outperform → Market Perform
2016-07-18 Downgrade Piper Jaffray Overweight → Neutral
2016-02-08 Aggiornamento Jefferies Hold → Buy
2015-11-05 Reiterato Northland Capital Outperform
2015-10-28 Iniziato Northland Capital Outperform
Mostra tutto

Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie

pulisher
07:44 AM

Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN

07:44 AM
pulisher
06:21 AM

Supernus Pharmaceuticals Inc. stock trendline breakdownWeekly Stock Report & Momentum Based Trading Ideas - newser.com

06:21 AM
pulisher
05:22 AM

Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com

05:22 AM
pulisher
05:01 AM

Can Supernus Pharmaceuticals Inc. stock continue upward trendDollar Strength & Fast Entry High Yield Stock Tips - newser.com

05:01 AM
pulisher
04:10 AM

Top chart patterns to watch in Supernus Pharmaceuticals Inc.2025 Market Trends & High Accuracy Buy Signal Tips - newser.com

04:10 AM
pulisher
12:53 PM

How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com

12:53 PM
pulisher
12:16 PM

Why Supernus Pharmaceuticals Inc. stock remains undervaluedBond Market & AI Forecasted Entry and Exit Points - newser.com

12:16 PM
pulisher
12:02 PM

Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com

12:02 PM
pulisher
Oct 30, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Long term hold vs stop loss in Supernus Pharmaceuticals Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What institutional flow reveals about Supernus Pharmaceuticals Inc.Treasury Yields & Community Verified Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo

Oct 29, 2025
pulisher
Oct 29, 2025

BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage of Supernus Pharmaceuticals (SUPN) with Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Supernus Pharmaceuticals Inc. stock near bottom after decline2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Using data models to predict Supernus Pharmaceuticals Inc. stock movementTrade Analysis Summary & Safe Entry Trade Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

It’s Clear How Big Money Flows Lift Supernus - Yahoo Finance

Oct 29, 2025
pulisher
Oct 28, 2025

Will Supernus Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Selloffs & Safe Entry Point Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Supernus Pharmaceuticals Inc. stock supported by strong fundamentalsWeekly Investment Summary & Smart Swing Trading Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Is Supernus Pharmaceuticals Inc. stock attractive after correctionEntry Point & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - sharewise.com

Oct 27, 2025

Supernus Pharmaceuticals Inc Azioni (SUPN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Supernus Pharmaceuticals Inc Azioni (SUPN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Khattar Jack A.
President, CEO
Oct 09 '25
Sale
50.57
59,900
3,029,336
1,206,578
NEWHALL CHARLES W III
Director
Oct 09 '25
Sale
50.77
25,000
1,269,234
104,644
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):